Havelka, A.; Larsson, A.O.; Mårtensson, J.; Bell, M.; Hultström, M.; Lipcsey, M.; Eriksson, M.
Analysis of Calprotectin as an Early Marker of Infections Is Economically Advantageous in Intensive Care-Treated Patients. Biomedicines 2023, 11, 2156.
https://doi.org/10.3390/biomedicines11082156
AMA Style
Havelka A, Larsson AO, Mårtensson J, Bell M, Hultström M, Lipcsey M, Eriksson M.
Analysis of Calprotectin as an Early Marker of Infections Is Economically Advantageous in Intensive Care-Treated Patients. Biomedicines. 2023; 11(8):2156.
https://doi.org/10.3390/biomedicines11082156
Chicago/Turabian Style
Havelka, Aleksandra, Anders O. Larsson, Johan Mårtensson, Max Bell, Michael Hultström, Miklós Lipcsey, and Mats Eriksson.
2023. "Analysis of Calprotectin as an Early Marker of Infections Is Economically Advantageous in Intensive Care-Treated Patients" Biomedicines 11, no. 8: 2156.
https://doi.org/10.3390/biomedicines11082156
APA Style
Havelka, A., Larsson, A. O., Mårtensson, J., Bell, M., Hultström, M., Lipcsey, M., & Eriksson, M.
(2023). Analysis of Calprotectin as an Early Marker of Infections Is Economically Advantageous in Intensive Care-Treated Patients. Biomedicines, 11(8), 2156.
https://doi.org/10.3390/biomedicines11082156